Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis

BACKGROUND: Recent clinical studies show that tyrosine kinase inhibitors slow the rate of lung function decline and decrease the number of acute exacerbations in patients with Idiopathic Pulmonary Fibrosis (IPF). However, in the murine bleomycin model of fibrosis, not all tyrosine kinase signaling i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: MacKenzie, BreAnne, Korfei, Martina, Henneke, Ingrid, Sibinska, Zaneta, Tian, Xia, Hezel, Stefanie, Dilai, Salma, Wasnick, Roxana, Schneider, Beate, Wilhelm, Jochen, El Agha, Elie, Klepetko, Walter, Seeger, Werner, Schermuly, Ralph, Günther, Andreas, Bellusci, Saverio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495640/
https://ncbi.nlm.nih.gov/pubmed/26138239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0242-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados